Search Results (45)

Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder. Revodiol Calming Cream^® (RCC) is a novel dermocosmetic product containing cannabidiol (CBD) and Annona cherimola fruit extract, designed for the management of atopic-prone and sensitive skin. Objective: Clinically assess the efficacy and safety of RCC in the management of atopic-prone and/or sensitive skin. Materials and methods: A prospective study included 20 adults and 22 children with mild-to-moderate atopic-prone skin. RCC was applied daily, for 56 days. Clinical evaluation included the SCORAD index, pruritus and dryness scales; and a Visual Analog Scale (VAS). Biometric assessments (Mexameter^®, Tewameter^®, Visioscan^®, Corneofix^®) were performed. Subjective satisfaction and quality of life (DLQI) were also recorded. Results: RCC was well tolerated, with no significant adverse events. After 56 days, SCORAD scores decreased by 55% in adults and 60% in children. Pruritus and dryness were significantly reduced, and VAS scores indicated a 65% decrease in discomfort. Biometric assessments demonstrated improvements in erythema, skin barrier function, topography, and desquamation. Subjective satisfaction reached 75% in both populations, and DLQI improved by 23%. Conclusions: The synergistic combination of CBD, Annona cherimola extract, and natural humectants offers a safe and effective daily dermocosmetic care for both adults and children. Full article

Background/Objectives: Uremic pruritus is a common complication in patients with end-stage kidney disease undergoing maintenance hemodialysis. Despite its high prevalence and substantial impact on sleep, psychological well-being, and overall quality of life, its pathophysiology remains multifactorial and incompletely understood. This narrative review summarizes contemporary evidence (2015–2025) on therapeutic strategies for uremic pruritus, with an emphasis on emerging treatments and evolving mechanistic insights. Methods: A PubMed search was conducted for original clinical studies published between 1 January 2015, and 31 October 2025, evaluating treatments for uremic pruritus in adult hemodialysis patients. Eligible study designs included randomized controlled trials and observational interventional studies. Non-English articles, pediatric studies, peritoneal dialysis studies, reviews, case reports, and studies of mixed-etiology pruritus were excluded. Earlier literature was reviewed to contextualize epidemiology and pathophysiology. Results: The review identifies multiple interacting mechanisms—including uremic toxins, immune dysregulation, mineral abnormalities, xerosis, neuropathic changes, and dysregulated opioid signaling—contributing to itch generation. Topical therapies, especially emollients and humectants, consistently improved symptoms with excellent safety profiles. Optimization of dialysis adequacy and membrane selection showed benefit in selected patients. Among systemic therapies, gabapentinoids demonstrated the most robust efficacy but required cautious dosing. Sertraline, nalbuphine, and difelikefalin showed significant antipruritic effects in controlled trials. Emerging therapies, including AST-120, omega-3 fatty acids, and the biologic dupilumab, demonstrated promising but preliminary results. Conclusions: Management of uremic pruritus requires a multifaceted, individualized approach integrating skin-directed therapies, dialysis optimization, and targeted systemic treatments. Ongoing research is needed to identify reliable biomarkers and to develop safer, more effective, mechanism-based therapies. Full article

Mycosporine-like amino acids (MAAs) are multifunctional, UV-absorbing and antioxidant metabolites produced by marine algae, offering promising applications in biotechnology and dermocosmetic sciences. In this study, MAAs were sustainably extracted from nori seaweed (Porphyra spp.) using an ultrasound-assisted aqueous method, an eco-friendly approach that ensures efficiency and industrial scalability. Chromatographic enrichment followed by MALDI-TOF mass spectrometry confirmed the presence of bioactive compounds, including porphyra-334, palythine, and myc-ornithine. The enriched fraction exhibited potent antioxidant activity (low IC₅₀ in DPPH and ABTS assays) and significant anti-elastase effects, highlighting its potential as a natural anti-aging agent. To optimize delivery, MAAs were incorporated into a stable water-in-oil nanoemulsion, which maintained droplet sizes below 400 nm and a low polydispersity index (PDI < 0.2) for up to four months. A randomized, double-blind clinical study in 20 volunteers further demonstrated that the MAA-based nanoemulsion significantly improved skin hydration (+53.6%) and reduced transepidermal water loss (TEWL), confirming its humectant and barrier-strengthening efficacy. These findings position Porphyra spp. as a sustainable marine resource for producing MAAs, and demonstrate their practical potential as natural, multifunctional ingredients in eco-conscious cosmetic and pharmaceutical formulations. Full article

This study aims to address the poor extensibility, brittleness, and limited hydration stability of pure sodium alginate (SA) hydrogels, which hinder their use in flexible, skin-adherent applications such as facial masks, by developing bio-based composites incorporating five representative functional additives: xanthan gum, guar gum, hydroxyethyl cellulose (HEC), poly(ethylene glycol)-240/hexamethylene diisocyanate copolymer bis-decyl tetradeceth-20 ether (GT-700), and Laponite^® XLG. Composite hydrogels were prepared by blending 1.5 wt% SA with 0.3 wt% of each additive in aqueous humectant solution, followed by ionic crosslinking using 3% (w/w) CaCl₂ solution. Physicochemical characterization included rotational viscometry, uniaxial tensile testing, ATR-FTIR spectroscopy, swelling ratio analysis, and pH measurement. Among them, the SA/XLG composite exhibited the most favorable performance, showing the highest viscosity, shear-thickening behavior, and markedly enhanced extensibility with an elongation at break of 14.8% (compared to 2.5% for neat SA). It also demonstrated a mean swelling ratio of 0.24 g/g and complete dissolution in water within one year. ATR-FTIR confirmed distinct non-covalent interactions between SA and XLG without covalent modification. The hydrogel also demonstrated excellent conformability to complex 3D surfaces, consistent hydration retention under centrifugal stress (+23.6% mass gain), and complete biodegradability in aqueous environments. Although its moderately alkaline pH (8.96) may require buffering for dermatological compatibility, its mechanical resilience and environmental responsiveness support its application as a sustainable, single-use skin-contact material. Notably, the SA/XLG composite hydrogel demonstrated compatibility with personalized fabrication strategies integrating 3D scanning and additive manufacturing, wherein facial topography is digitized and transformed into anatomically matched molds—highlighting its potential for customized cosmetic and biomedical applications. Full article

This review offers an in-depth analysis of microbial γ-poly-glutamic acid (γ-PGA), highlighting its production, biosynthetic pathways, unique properties, and extensive applications in the food and health industries. γ-PGA is a naturally occurring biopolymer synthesized by various microorganisms, particularly species of Bacillus. The report delves into the challenges and advancements in cost-effective production strategies, addressing the economic constraints associated with large-scale γ-PGA synthesis. Its biocompatibility, biodegradability, and non-toxic nature make it a promising candidate for diverse industrial applications. γ-PGA’s exceptional water-holding capacity and humectant properties are key to its utility in the food industry. These features enable it to enhance the stability, viscosity, and shelf life of food products, making it a valuable ingredient in processed foods. The review highlights its ability to improve the textural quality of baked goods, stabilize emulsions, and act as a protective agent against staling. Beyond food applications, γ-PGA’s role in health and pharmaceuticals is equally significant. Its use as a drug delivery carrier, vaccine adjuvant, and biofilm inhibitor underscores its potential in advanced healthcare solutions. Full article

Fluoride contamination in water sources presents critical public health challenges, particularly in regions where groundwater exhibits elevated fluoride levels. Chronic exposure can result in dental and skeletal fluorosis, necessitating efficient and sustainable remediation strategies. This study investigates the spherical agglomeration technique (SAT) as an alternative fluoride removal method, assessing the performance of sunflower oil versus n-heptane as humectants and evaluating the synergistic effects of Agave durangensis leaf extract. A factorial experimental design optimized dosage parameters in aqueous models and well water samples, ensuring reliable fluoride removal. Sunflower oil significantly outperformed n-heptane, achieving fluoride removal efficiencies of up to 95.19% under optimal conditions (5 mL _Hum/g _TMCs at pH 6.5). Incorporating A. durangensis extract sustained high fluoride removal while reducing the required extract dosage to 0.5 g _Extr/g _TMCs. When applied to well water samples, the SAT consistently maintained an 88.9% fluoride removal efficiency. Compared to conventional methods such as coagulation–flocculation and adsorption, the SAT demonstrated enhanced effectiveness with a lower environmental footprint. These findings reinforce the viability of sunflower oil and A. durangensis extract as eco-friendly alternatives to n-heptane, positioning the SAT as a scalable, cost-effective solution for large-scale fluoride remediation. Full article

Artemisia vestita Wall. ex Besser, a traditional medicinal plant with healing properties, is receiving significant attention as a potential therapeutic agent for wound healing. In this study, eight Artemisia vestita leaf extract hydrogel formulations (F1–F8) were carefully designed and studied. The hydrogel formulations contained A. vestita leaf extract, tragacanth gum, humectants, preservatives, pH stabilizers, and Milli-Q water. A preformulation study was conducted to ensure safety and efficacy. Moreover, various experiments assessed the potential application and characteristics of A. vestita leaf extract hydrogel (ALEH). Drug release and swelling studies were conducted at different pH levels and temperatures. The best drug release model was identified based on the regression coefficient (R²). Antimicrobial efficacy was assessed using the agar well diffusion method, and wound healing in HaCat cells was assessed using the scratch assay. ALEH exhibited non-Fickian diffusion, with higher drug release noted at pH 6.8 than at pH 4.5, indicating pH-responsive behavior. It exhibited significant antimicrobial activity against various strains and achieved 95% wound closure after 24 h in vitro, indicating strong wound healing properties. It also had a long shelf life; therefore, it could have pharmaceutical and medical applications. Our study is the first to report the potential applications of ALEH in skincare and wound management. Full article

In order to explore the extraction and activity of macroalge glycolipids, six macroalgae (Bangia fusco-purpurea, Gelidium amansii, Gloiopeltis furcata, Gracilariopsis lemaneiformis, Gracilaria sp. and Pyropia yezoensis) glycolipids were extracted with five different solvents firstly. Considering the yield and glycolipids concentration of extracts, Bangia fusco-purpurea, Gracilaria sp. and Pyropia yezoensis were selected from six species of marine macroalgae as the raw materials for the extraction of glycolipids. The effects of the volume score of methanol, solid–liquid ratio, extraction temperature, extraction time and ultrasonic power on the yield and glycolipids concentration of extracts of the above three macroalgae were analyzed through a series of single-factor experiments. By analyzing the antioxidant activity in vitro, moisture absorption and moisturizing activity, the extraction process of Bangia fusco-purpurea glycolipids was further optimized by response surface method to obtain suitable conditions for glycolipid extraction (solid-liquid ratio of 1:27 g/mL, extraction temperature of 48 °C, extraction time of 98 min and ultrasonic power of 450 W). Bangia fusco-purpurea extracts exhibited a certain scavenging effect on DPPH free radicals, as well as good moisture-absorption and moisture retaining activities. Two glycolipids were isolated from Bangia fusco-purpurea by liquid–liquid extraction, silica gel column chromatography and thin-layer chromatography, and they showed good scavenging activities against DPPH free radicals and total antioxidant capacity. Their scavenging activities against DPPH free radicals were about 60% at 1600 µg/mL, and total antioxidant capacity was better than that of Trolox. Among them, the moisturizing activity of a glycolipid was close to that of sorbierite and sodium alginate. These two glycolipids exhibited big application potential as food humectants and antioxidants. Full article

Heated Tobacco Products (HTPs) purport to reduce exposure to tobacco-related toxicants compared to combustible cigarettes. This cross-sectional study examined the content of nicotine, two humectants (propylene glycol (PG) and vegetable glycerin (VG)), and four tobacco-specific nitrosamines (TSNAs: NNN, NNK, NAT, and NAB) in the tobacco filler of a popular HTP brand (IQOS). Non-menthol and menthol IQOS sticks were purchased from nine countries between 2017 and 2020 and were classified into two versions (“Bold” and “Light”) using Philip Morris’s flavor descriptors. The average nicotine concentration was 4.7 ± 0.5 mg/stick, and the highest nicotine concentration was found in products from Japan (5.1 ± 0.2 mg/stick). VG was the dominant humectant found in all sticks, with an average concentration of (31.5 ± 2.3 mg/stick). NNN, NNK, and NAT were substantially higher in the “Bold” sticks than the “Light” sticks. Significant differences between countries for TSNAs were also observed: the NAT and NAB contents were the highest in the “Light” products from Canada (192.5 ± 24.1 and 22.9 ± 1.0 ng/stick, respectively); the NNK concentration was the highest in the “Bold” products from Poland (64.8 ± 7.9 ng/stick); and the highest NNN concentrations were observed in the “Bold” products from South Africa (488.9 ± 26.7 ng/stick). As NNN and NNK are known human carcinogens, and as humectants like PG and VG can degrade into toxic carbonyl compounds upon heating, monitoring the concentration of these chemicals in HTPs is important for protecting users’ health and ensuring compliance with regulations. Full article

This study analyzed the impact of LED light on bioemulsifier production by Aureobasidium pullulans LB83 in solid-state fermentation (SSF) using pre-treated sugarcane bagasse (PSB). The biomass was subjected to alkaline pre-treatment and conducted fermentations in Erlenmeyer flasks containing 2 g of PSB that were immersed in a humectant solution with a cell concentration of 10⁸ cells/mL. The screening involved varying LED light wavelengths (green, red, orange, and blue) over a 7-day period at 28 °C. Notably, under the influence of blue light, the process achieved maximum production, yielding an EI_24% of 63.9% and 45.1% for soybean oil and kerosene, respectively. Prolonged exposure to blue light for 11 days at 28 °C resulted in maximum bioemulsifier production (75%) and cellulolytic enzyme activity (3.67 IU g⁻¹ for endoglucanase and 0.41 IU g⁻¹ for exoglucanase) with soybean oil and kerosene. Experiments in a bioreactor, with varying light conditions (dark, white light, and blue LED light), demonstrated that the blue LED bioreactor outperformed others, achieving EI_24% values of 55.0% and 45.7% for soybean oil and kerosene, respectively. The scanning electron microscopy (SEM) confirmed yeast growth under these conditions after 9 days. Our findings highlight the significant potential of LED light to enhance bioemulsifier production by A. pullulans LB83 from PSB. Full article

With the development of camel-derived food and pharmaceutical cosmetics, camel hoof, as a unique by-product of the camel industry, has gradually attracted the attention of scientific researchers in the fields of nutrition, health care, and biomaterial development. In this study, the protein composition and collagen type of Bactrian camel hoof collagen extract (CHC) were analyzed by LC-MS/MS, and the functional properties of CHC were further investigated, including its rheological characteristics, emulsification and emulsion stability, and hygroscopicity and humectancy. Proteomic identification confirmed that CHC had 13 collagen subunits, dominated by type I collagen (α1, α2), with molecular weights mainly in the 100–200 KDa range and a pI of 7.48. An amino acid study of CHC revealed that it carried the standard amino acid profile of type I collagen and was abundant in Gly, Pro, Glu, Ala, and Arg. Additionally, studies using circular dichroism spectroscopy and Fourier transform infrared spectroscopy revealed that CHC contains a collagen-like triple helix structure that is stable and intact. Different concentrations of CHC solutions showed shear-thinning flow behavior. Its tan δ did not differ much with increasing concentration. The CHC has good emulsifying ability and stability, humectancy, and hygroscopicity. This study provides a basis for utilizing and developing Bactrian camel hoof collagen as a functional ingredient. Full article

Biosurfactants (BSs) are microbial compounds that have emerged as potential alternatives to chemical surfactants due to their multifunctional properties, sustainability and biodegradability. Owing to their amphipathic nature and distinctive structural arrangement, biosurfactants exhibit a range of physicochemical properties, including excellent surface activity, efficient critical micelle concentration, humectant properties, foaming and cleaning abilities and the capacity to form microemulsions. Furthermore, numerous biosurfactants display additional biological characteristics, such as antibacterial, antifungal and antiviral effects, and antioxidant, anticancer and immunomodulatory activities. Over the past two decades, numerous studies have explored their potential applications, including pharmaceuticals, cosmetics, antimicrobial and antibiofilm agents, wound healing, anticancer treatments, immune system modulators and drug/gene carriers. These applications are particularly important in addressing challenges such as antimicrobial resistance and biofilm formations in clinical, hygiene and therapeutic settings. They can also serve as coating agents for surfaces, enabling antiadhesive, suppression, or eradication strategies. Not least importantly, biosurfactants have shown compatibility with various drug formulations, including nanoparticles, liposomes, micro- and nanoemulsions and hydrogels, improving drug solubility, stability and bioavailability, and enabling a targeted and controlled drug release. These qualities make biosurfactants promising candidates for the development of next-generation antimicrobial, antibiofilm, anticancer, wound-healing, immunomodulating, drug or gene delivery agents, as well as adjuvants to other antibiotics. Analysing the most recent literature, this review aims to update the present understanding, highlight emerging trends, and identify promising directions and advancements in the utilization of biosurfactants within the pharmaceutical and biomedical fields. Full article

Diabetic foot syndrome is the leading cause of limb loss due to non-healing ulcers. Repeated injuries, abnormal foot loads, and ischemia lead to ulcers. Poor shoe selection and inadequate care worsen the situation. Lack of patient education contributes to bacterial infections, tissue necrosis, and amputation. Vigilant observation and regular care can reduce wound size and prevent new wounds. Cleansing, infection control, and pressure relief are crucial in diabetic foot treatment. In this review, the effect of selected active ingredients and natural raw materials used for topical application in the care of diabetic foot was analyzed. The main focus used was on ingredients of natural origin—research studies utilizing emollients, humectants, plant extracts, and animal-derived ingredients were discussed. In addition, research studies on the application of nanomaterials, ozone and stem cells are also discussed. The cosmetics industry and manufacturers of podiatric products play a vital role in diabetic care. They should prioritize proper formulation, optimal ingredient doses, and skin microbiome control. Educating diabetics and using cosmetic products with self-massage elements can reduce the risk of hard-to-heal ulcers. Full article

The objective of this study was to create polymeric dressings, microfibers, and microneedles (MN) loaded with ceftriaxone, using PMVA (Poly (Methyl vinyl ether-alt-maleic acid), Kollicoat^® 100P, and Kollicoat^® Protect as polymers to treat diabetic wounds and accelerate their recovery. These formulations were optimized through a series of experiments and were subsequently subjected to physicochemical tests. The results of the characterization of the dressings, microfibers, and microneedles (PMVA and 100P) were, respectively, a bioadhesion of 281.34, 720, 720, 2487, and 510.5 gf; a post-humectation bioadhesion of 186.34, 831.5, 2380, and 630.5 gf, tear strength of 2200, 1233, 1562, and 385 gf, erythema of 358, 8.4, 227, and 188; transepidermal water loss (TEWL) of 2.6, 4.7, 1.9, and 5.2 g/h·m²; hydration of 76.1, 89.9, 73.5, and 83.5%; pH of 4.85, 5.40, 5.85, and 4.85; and drug release (Peppas kinetics release) of n: 0.53, n: 0.62, n: 0.62, and n: 0.66). In vitro studies were performed on Franz-type diffusion cells and indicated flux of 57.1, 145.4, 718.7, and 2.7 µg/cm²; permeation coefficient (Kp) of 13.2, 19.56, 42, and 0.00015 cm²/h; and time lag (t_L) of 6.29, 17.61, 27. 49, and 22.3 h, respectively, in wounded skin. There was no passage of ceftriaxone from dressings and microfibers to healthy skin, but that was not the case for PMVA/100P and Kollicoat^® 100P microneedles, which exhibited flux of 194 and 0.4 µg/cm², Kp of 11.3 and 0.00002 cm²/h, and t_L of 5.2 and 9.7 h, respectively. The healing time of the formulations in vivo (tests carried out using diabetic Wistar rats) was under 14 days. In summary, polymeric dressings, microfibers, and microneedles loaded with ceftriaxone were developed. These formulations have the potential to address the challenges associated with chronic wounds, such as diabetic foot, improving the outcomes. Full article

Unconventional polysaccharides as representative active substances from stems of Trollius chinensis Bunge (TC) were studied. Crude polysaccharides from the stems of TC (TCSP) and the petals of TC (TCPP) were extracted, and the moisture retention and antioxidation activities of both TCSP and TCPP in vitro were studied. The weight-average molar masses (M_w) of TCSP (6.07 × 10⁵ Da) were lower than those of TCPP (9.72 × 10⁵ Da). Glucuronic acid and xylose only existed in TCSP, and the molar ratio of galacturonic acid and mannose in TCSP was significantly higher than that in TCPP. No significant differences in moisture retention ability were found between TCSP and TCPP. The reducing capacity and dphenyl picryl hydrazinyl (DPPH) radical scavenging capacity of TCSP were slightly weaker than those of TCPP. The 2,2-azino-bis (3-ethylbenzothiazoline–6-sulfonic acid) (ABTS) radical scavenging capacity of TCSP can be equivalent to that of TCPP. The moisture retention ability was not different between TCSP and TCPP, which are both highly homologous with traditional humectants. The antioxidation assays in vitro demonstrated that the antioxidant activity of TCSP is stronger compared to that of some plant-derived polysaccharides. The stems of TC can be a promising source of unconventional polysaccharides, which possess moisture retention and antioxidation capacities for the cosmetics industry. Full article